🔬Causal Models Need Causal Data - Xaira’s X-Cell model for Drug Discovery (Bo Wang & Ci Chu, Chief Discovery Officer & Chief AI Scientist)
- ID
- 6559
- Status
- summarized
- Published
- 22 Jul 2026, 3:34 AM
- Fetched
- 22 Jul 2026, 4:58 AM
- Provider
- Latent Space
- Category
- developer-ai
- Original URL
- https://www.latent.space/p/xaira
- Source URL
- https://www.latent.space/feed
Summary
- Score
- 7.0
- Created
- 22 Jul 2026, 4:59 AM
- Tags
- Audience
- developersai-ml-learnerssaas-startup-founders
What happened
Xaira Therapeutics is betting heavily on purpose-built data generation to train causal models for drug discovery, with Bo Wang and Ci Chu explaining their X-Cell model approach. The core thesis is that causal models require causally-generated data rather than repurposed observational datasets.
Why it matters
For builders working on AI/ML pipelines, this is a concrete case study on why data strategy—not just model architecture—determines outcomes in high-stakes domains. Malaysian startups and researchers in healthtech or deep tech can take lessons on investing in proprietary data generation rather than relying on existing public datasets, which is especially relevant as local biotech and AI initiatives grow.
Discussion angle
Discuss how the 'causal models need causal data' principle applies beyond pharma—what does it mean for Malaysian builders who often default to scraping or buying data instead of generating purpose-built datasets?